Klencke Barbara
SEC-identified person · CIK 1647647 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tscan Therapeutics, Inc. TCRX | Director | filed 2023–2026 |
| ALX Oncology Holdings INC ALXO | Director · Chief Medical Officer | filed 2025–2026 |
| Xencor Inc XNCR | Director | filed 2023–2025 |
| Effector Therapeutics, Inc. LWAC | Director | filed 2021–2024 |
| Sierra Oncology, Inc. SRRA | Chief Medical Officer | filed 2015–2022 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.